Trials / Completed
CompletedNCT01057316
Formula PTX Renal Stent Clinical Study
Evaluation of Safety and Effectiveness of the Formula PTX Balloon-Expandable Stent for Renal Artery Stenosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and effectiveness of the PTX-coating on the Formula PTX Balloon-Expandable Stent in treatment of renal artery stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Formula PTX Stent - Dose 1 | Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded. |
| DEVICE | Formula PTX Stent - Dose 2 | Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded. |
| DEVICE | Formula PTX Stent - Dose 3 | Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2014-01-01
- Completion
- 2018-04-09
- First posted
- 2010-01-27
- Last updated
- 2018-06-01
Locations
12 sites across 4 countries: Czechia, France, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01057316. Inclusion in this directory is not an endorsement.